Histone cluster 1 H2AI Inhibitors represent a specialized category of chemical compounds designed to selectively obstruct the activity of histone cluster 1, with a specific focus on the H2AI subtype. Histones are essential proteins involved in packaging DNA into nucleosomes, forming the structural basis of chromatin. The designation H2AI identifies a variant of histone H2A, one of the core histones crucial for nucleosome assembly. The H2A family of histones plays a central role in the regulation of gene expression and the modulation of chromatin architecture. Inhibitors developed for Histone cluster 1 H2AI are meticulously crafted for specificity, aiming to selectively bind to key regions of this histone variant. This interaction potentially affects its binding to DNA and other proteins, thereby modulating chromatin dynamics.
The development of Histone cluster 1 H2AI Inhibitors necessitates an in-depth understanding of the structural characteristics of histone H2AI and its unique role within chromatin organization. These inhibitors are engineered with precision, aiming to selectively bind to crucial regions of Histone cluster 1 H2AI and disrupt its normal functions. By employing these inhibitors in experimental contexts, researchers can investigate the consequences of inhibiting this particular histone variant, unraveling insights into chromatin remodeling and the intricate regulation of gene expression. The study of histones, including variants like H2AI, significantly contributes to advancing our understanding of epigenetic mechanisms, offering crucial insights into the dynamic processes governing gene regulation and the complex orchestration of cellular functions at the chromatin level.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
Entinostat is a histone deacetylase inhibitor, altering chromatin structure and potentially impacting the acetylation status of histones, including H2AK. | ||||||
GSK-J4 | 1373423-53-0 | sc-507551 | 100 mg | $1275.00 | ||
GSK-J4 inhibits lysine demethylase, potentially influencing histone demethylation and the transcriptional regulation of genes, including H2AK. | ||||||
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
EPZ-6438 targets EZH2, a histone methyltransferase, potentially impacting the methylation of histones and the expression of genes like H2AK. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $153.00 $561.00 | ||
Belinostat is a histone deacetylase inhibitor, impacting chromatin structure and potentially affecting the acetylation status of histones, including H2AK. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
UNC1999 targets the methyltransferase activity of histone methyltransferase, possibly impacting the methylation status and expression of H2AK. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a potent histone deacetylase inhibitor, influencing gene expression by maintaining acetylation levels on histones, including H2AK. | ||||||
GSK126 | 1346574-57-9 | sc-490133 sc-490133A sc-490133B | 1 mg 5 mg 10 mg | $90.00 $238.00 $300.00 | ||
GSK343 inhibits EZH2, potentially influencing histone methylation patterns and the transcriptional regulation of genes, including Histone cluster 1 H2AK. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
I-BET151 is a BET bromodomain inhibitor, disrupting interactions between bromodomain proteins and acetylated histones, potentially influencing gene expression, including H2AK. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $260.00 $925.00 | 5 | |
C646 is a selective inhibitor of histone acetyltransferase, modulating the acetylation of histones and influencing the expression of associated genes, including H2AK. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
UNC0638 inhibits G9a, a histone methyltransferase, potentially influencing the methylation status of histones and the expression of genes, including H2AK. |